Reuters logo
BRIEF-Oncosec announces clinical collaboration with Merck
2017年5月10日 / 上午10点35分 / 6 个月前

BRIEF-Oncosec announces clinical collaboration with Merck

May 10 (Reuters) - Oncosec Medical Inc

* Oncosec announces clinical collaboration with Merck to evaluate combination of immunopulse IL-12 and keytruda(pembrolizumab) for metastatic melanoma

* Additional details of collaboration were not disclosed

* Says under agreement, Oncosec will sponsor and fund study and Merck will provide keytruda Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below